Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial-Reference-Cited by-同舟云学术

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial

Published:2018-09 Issue:10153 Volume:392 Page:1117-1126
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lansky Alexandra,Wijns William,Xu Bo,Kelbæk Henning,van Royen Niels,Zheng Ming,Morel Marie-angèle,Knaapen Paul,Slagboom Ton,Johnson Thomas W,Vlachojannis Georgios,Arkenbout Karin E,Holmvang Lene,Janssens Luc,Ochala Andrzej,Brugaletta Salvatore,Naber Christoph K,Anderson Richard,Rittger Harald,Berti Sergio,Barbato Emanuele,Toth Gabor G,Maillard Luc,Valina Christian,Buszman Paweł,Thiele Holger,Schächinger Volker,Baumbach Andreas

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis;Stettler;Lancet,2007

2. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents;Spaulding;N Engl J Med,2007

3. Vascular responses to drug eluting stents: importance of delayed healing;Finn;Arterioscler Thromb Vasc Biol,2007

4. Polymer coatings and delayed arterial healing following drug-eluting stent implantation;Byrne;Minerva Cardioangiol,2009

5. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial;The Lancet;2024-09

2. Long-Term Percutaneous Coronary Intervention Outcomes in Chronic Versus Acute Coronary Syndromes (TARGET All Comers Trial);The American Journal of Cardiology;2024-04

3. Comparison of emulsion and spray methods for fabrication of rapamycin-loaded acetalated dextran microparticles;RSC Pharmaceutics;2024

4. Polymers, thickness, dosage: just pieces of the whole puzzle;EuroIntervention;2023-12

5. Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial;EuroIntervention;2023-12